Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2022 Nov 1.
Published in final edited form as: JAMA Psychiatry. 2021 Nov 1;78(11):1284–1285. doi: 10.1001/jamapsychiatry.2021.2790

Association of Alcohol With Cortical Thickness in Adolescents-Reply

Matthew D Albaugh 1, Max M Owens 1, Hugh Garavan 1
PMCID: PMC8958978  NIHMSID: NIHMS1788378  PMID: 34586353

Letters

COMMENT & RESPONSE

In Reply We thank Kung et al for their thoughtful comments regarding the association of alcohol use with our findings.1 The potential confounding or interactive associations of alcohol use when investigating cannabis associations is a perennial challenge with human research, but a number of analyses lead us to conclude that the cortical thinning we reported was most strongly associated with cannabis exposure.

First, we examined the association between AUDIT Alcohol Consumption (AUDIT-C) score and cortical thickness at 5-year follow-up in prefrontal regions we found to be associated with cannabis use (ie, regions shown in Figure 1 from our study1). Cannabis use was not included as a covariate in these analyses. There was no significant association between alcohol consumption and mean cortical thickness of left (t786 = −1.32, P = .19) or right prefrontal (t786 = −1.91, P = .06) regions of interest while controlling for age, total brain volume, sex, handedness, and site. When the same analyses were repeated, replacing alcohol consumption score with cannabis use, cannabis use was significantly associated with left (t786 = −3.69, P < .001) and right prefrontal (t786 = −4.33, P < .001) thickness. To assess whether alcohol exposure was exacerbating the cannabis associations, we tested for an AUDIT-C score by cannabis use interaction on cortical thickness in the same ROIs. No significant interactions were observed (P > .19).

We then conducted a vertex-level analysis examining the association between AUDIT-C score and cortical thickness at 5-year follow-up while controlling for the same nuisance variables. Cannabis use was not included as a covariate. No associations survived correction, even when lowering the initial height threshold to P = .01. Further, no evidence of a significant AUDIT-C score by cannabis use interaction was observed at the vertex level.

Next, we examined the association between AUDIT-C score and within-participant cortical thinning in the prefrontal regions shown in Figure 2 from our study.1 Nuisance covariates but not cannabis use were included in models. AUDIT-C score at follow-up was only nominally associated with symmetrized percent change in left (t786 = −2.20, P = .03) and right prefrontal (t786 = −2.05, P = .04) regions of interest, and these associations did not survive correction for multiple comparisons. When cannabis use was entered into these models, alcohol use was no longer significantly associated with thinning in these regions of interest (P > .20). Moreover, while the cannabis use association was significant, there were no significant AUDIT-C score by cannabis use interactions.

To further address the possibility of other substances driving these cannabis-related associations, we used bayesian causal network (BCN) modeling2 to explore potential causal relationships among prefrontal cortical thinning and adolescent nicotine, alcohol, and cannabis use. Using data from Albaugh et al,1 we tested multiple network structure learning algorithms to build BCNs characterizing the potential relationship between prefrontal cortical thinning and substance use.3 BCN models included tobacco and alcohol use at baseline and follow-up, in addition to cannabis use at follow-up (no participants had used cannabis at baseline). All BCN models strongly suggested a directional relationship of cannabis use between ages 14 and 19 years on accelerated thinning during that same period. They did not indicate a causal relationship of alcohol or tobacco on accelerated thinning. Our findings appear consistent with animal research on adolescent tetrahydrocannabinol exposure and prefrontal cortical maturation.4

Conflict of Interest Disclosures:

Dr Albaugh reported receiving grants from the National Institute of Mental Health and Brain & Behavior Research Foundation during the conduct of the study. No other disclosures were reported.

References

  • 1.Albaugh MD, Ottino-Gonzalez J, Sidwell A, et al. ; IMAGEN Consortium. Association of cannabis use during adolescence with neurodevelopment. JAMA Psychiatry. Published online June 16, 2021. doi: 10.1001/jamapsychiatry.2021.1258 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Pearl J Causality: models, reasoning and inference. 2nd ed. Cambridge University Press; 2009. doi: 10.1017/CBO9780511803161 [DOI] [Google Scholar]
  • 3.Owens MM, Albaugh MD, Allgaier N, et al. Bayesian causal network modeling suggests adolescent cannabis use promotes accelerated dorsal prefrontal thinning. PsyArXiv. Preprint posted on August 9, 2021. doi: 10.31234/osf.io/2fzjp [DOI] [Google Scholar]
  • 4.Miller ML, Chadwick B, Dickstein DL, et al. Adolescent exposure to Δ9-tetrahydrocannabinol alters the transcriptional trajectory and dendritic architecture of prefrontal pyramidal neurons. Mol Psychiatry. 2019;24(4):588–600. doi: 10.1038/s41380-018-0243-x [DOI] [PMC free article] [PubMed] [Google Scholar]

RESOURCES